Preclinical Development of siRNA Therapeutics for AL Amyloidosis

AL (amyloid light chain) amyloidosis is a rare hematologic disorder characterized by the accumulation of a misfolded monoclonal immunoglobulin light chain (LC) as fibrillar protein deposits. Current treatments, including cytotoxic chemotherapy and immunomodulatory therapy, are directed at killing th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hovey, Beth M., Ward, Jennifer E., Hoo, Pamela Soo, O’Hara, Carl J., Connors, Lawreen H., Seldin, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155733/
https://www.ncbi.nlm.nih.gov/pubmed/21562591
http://dx.doi.org/10.1038/gt.2011.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155733/
https://www.ncbi.nlm.nih.gov/pubmed/21562591
http://dx.doi.org/10.1038/gt.2011.69

Ejemplares similares